News chronological

Latest News

WASHINGTONPOST (Rachel Roubein) - Trump administration paving way for temporary sale of some unapproved peptides

Food and Drug Administration scientists and some medical experts have raised alarms about increasing access to certain peptides.

Sourcehttps://www.washingtonpost.com/health/2026/10/07/trump-administration-paving-way-temporary-sale-some-unapproved-peptides/
Keywordstrumpfdapeptideshealthcaremedicinepharmaceuticalswellnesspublic-healthcompounding-pharmacyregulationbiotechhealthhealth-policylongevitysciencetelehealthdrug-regulationfederal-governmentglp-1big-pharmabiohackingclinical-trialsfda-panelgray-markethealthcare-policymedicationpolicywashington-politicsweight-lossagencychinacompounding-pharmaciesconsumer-protectionconsumer-safetydrug-compoundingdrug-safetyfda-advisory-committeefda-approvalgovernment-agencyhealthcare-regulationmedical-industrymedical-regulationozempicpharmacyprescription-drugs
Notify Channelt.me/News_Wire2
Permalinkhttps://news.site.please-be-patient.com/news/1168590/trump-administration-paving-way-for-temporary-sale-of-some-unapproved-peptides

Related article: THENATIONALPULSE (The National Pulse): China’s Fentanyl Suppliers Eye Their Next American Market. •

Related article: NYTIMES (Christina Jewett and Dani Blum): FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes •

Related article: NPR (Will Stone): What would it take to get peptides on the shelf? •

Related article: NPR (Will Stone): Peptides get their regulatory closeup •

Related article: NPR (Will Stone): FDA panel considers easing peptide restrictions •

Related article: NPR (Will Stone): What's behind the push to make peptide therapies more readily available •

Related article: NYTIMES (Christina Jewett and Dana G. Smith): A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda •

Related article: NYTIMES (Christina Jewett and Dana G. Smith): F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom •

Related article: NPR (Will Stone): FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports •

Related article: NPR (Will Stone): The wellness world is eager for RFK Jr.'s promised move on peptides •

Related article: AMERICANGREATNESS: FDA Panel Backs Wider Access to Six Peptide Therapies, Citing Grey Market Concerns •

Related article: AMERICANALMANAC (Jonah Adams): FDA panel stacked with peptide industry insiders reviews unproven injections backed by RFK Jr. •

Related article: NYTIMES (Dana G. Smith): What to Know About Peptides the FDA Is Considering for Use •

Related article: PRAGERU (BitChute): Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 .. •

From related PRAGERU (BitChute): Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 ..
What topics did Dr. Jared Ament and Dr. Jon Kanevsky cover concerning medical practice and patient research?
They discussed why good medicine requires both curiosity and humility, as well as the role that AI plays in helping patients conduct their own health research.
Q&A ID bf433dd4-cc68-4d3a-8be0-e6982238e787
From related PRAGERU (BitChute): Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 ..
What are some of the risks mentioned regarding the peptide industry?
The discussion highlights that the gray-market peptide industry can be risky and raises questions about how much people truly know about what they are putting into their bodies.
Q&A ID 2395d233-6540-43d5-9417-43f4b11c7cb3
From related PRAGERU (BitChute): Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 ..
What specific health-related topics and substances were discussed by Dr. Jared Ament and Dr. Jon Kanevsky?
The discussion covered peptides, supplements, GLP-1 weight-loss drugs, NAD, IV drips, “longevity stacks,” FDA approval, third-party testing, China-based sourcing, growth hormone peptides, Ozempic, retatrutide, creatine, and the role of AI in helping patients research their own health.
Q&A ID c25ab39d-eac1-4921-a497-fd94fcec3029
From related PRAGERU (BitChute): Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 ..
Who were the featured medical experts in the discussion regarding peptides and longevity stacks on September 23, 2026?
The discussion featured Dr. Jared Ament and Dr. Jon Kanevsky.
Q&A ID 73b4b4b6-08b3-4d77-8e11-9a8531715e47

Related article: ABCNEWS: FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next? •

Related article: THENATIONALPULSE (Pulse Wires): More Pharma Firms Want to Make Drug Price Deals With Trump. •

Related article: THE HILL (Youtube): FDA eases regulations on vaping industry in sharp pivot from previous administrations •

Related article: THE HILL (Youtube): FDA eases regulations on vaping industry in sharp pivot from previous administrations •

Related article: AXIOS (Tina Reed): RFK Jr.'s peptide push could become next wellness boom •

Related article: NEWSNATIONNOW (Elizabeth Vargas): China is profiting from America's peptide interest: Former DHS chief •

From related NEWSNATIONNOW (Elizabeth Vargas): China is profiting from America's peptide interest: Former DHS chief
What are the specific concerns regarding peptide products currently booming in popularity?
Critics warn that many peptide products may be unregulated and imported from China, and they are being marketed with little oversight.
Q&A ID 6da9f9e1-66ad-4268-989d-18fd92f198b0
From related NEWSNATIONNOW (Elizabeth Vargas): China is profiting from America's peptide interest: Former DHS chief
According to a former DHS chief, how is China benefiting from the growing interest in peptides in America?
China is profiting from America's peptide interest, as critics warn that many peptide products may be imported from China and marketed with little oversight.
Q&A ID 6c404ba1-c914-448a-bfbb-90ee37b13e8e
Latest News